Research Article

Exploring the Mechanism of Weikang Keli in Inhibiting Gastric Cancer through the MAPK Signaling Pathway: Based on Network Pharmacology and Experimental Verification

Figure 1

(a) “Active ingredient-target” network of WK. (b) PPI network of cross targets of WK and gastric cancer. (c) Bar graph of GO enrichment in the treatment of gastric cancer with WK. (d) Enrichment bubble chart of pathway for WK in gastric cancer treatment. (e) Internal potential module network and function description of the PPI network of WK in gastric cancer.
(a)
(b)
(c)
(d)
(e)